Cresemba and Colace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Colace (docusate ). Common drug interactions include malignant neoplasm progression among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Colace. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Colace?

Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 41,841 Colace users. Check the latest studies of Colace.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

50 people who take Cresemba and Colace together, and have interactions are studied.

What are the common drug interactions of Cresemba and Colace, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Mobility decreased (ability to move is reduced)
Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)
Obliterative bronchiolitis (bronchiolar inflammation)
Oedema peripheral (superficial swelling)
Palpitations (feelings or sensations that your heart is pounding or racing)
Productive cough
Pyrexia (fever)

male:

Pyrexia (fever)
Hypotension (abnormally low blood pressure)
Blood creatinine increased
Blood lactic acid increased
Blood urea increased
Bone marrow failure
Bradycardia (abnormally slow heart action)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytokine storm (over-protective immune response that can actually be fatal)
Delirium (wild excitement)

What are the common drug interactions of Cresemba and Colace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Septic shock (shock due to blood infection)
Somnolence (a state of near-sleep, a strong desire for sleep)
Staphylococcal infection (an infection with staphylococcus bacteria)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Blood creatinine increased
Blood lactic acid increased

20-29:

Blood potassium increased
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)

30-39:

Cellulitis (infection under the skin)
Neutropenia (an abnormally low number of neutrophils)
Overdose
Upper respiratory tract infection
White blood cell count decreased

40-49:

Blood bilirubin increased
Confusional state
Delirium (wild excitement)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Eye swelling
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Mucosal inflammation (infection of mucous membrane)
Neutropenia (an abnormally low number of neutrophils)
Orbital oedema (swelling of orbit)
Pyrexia (fever)

50-59:

Blood pressure decreased
Cerebral microhaemorrhage (bleeding in brain less than 5 mm in size)
Chest pain
Chronic respiratory failure
Complications of transplanted lung
Diarrhoea
Disease recurrence
Dyspnoea (difficult or laboured respiration)
Encephalomalacia (localized softening of the brain substance, due to haemorrhage or inflammation)
Gait disturbance

60+:

Febrile neutropenia (fever with reduced white blood cells)
Arthralgia (joint pain)
Nodule (a growth of abnormal tissue)
Pyrexia (fever)
Anaemia (lack of blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Apnoea (suspension of external breathing)
Delirium (wild excitement)
Diarrhoea

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 34.00%
Pain: 9 people, 18.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 14.00%
Nausea (feeling of having an urge to vomit): 6 people, 12.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.00%
Back Pain: 6 people, 12.00%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 5 people, 10.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 8.00%
Insomnia (sleeplessness): 4 people, 8.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 4 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Colace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously